Mitochondrial dysfunction in Parkinson's disease: Pathogenesis and neuroprotection

Parkinson's Disease

Volumn , Issue , 2011, Pages

  Teismann, Peter ^a   Mounsey, Ross B ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; ANTIOXIDANT; CREATINE; CYPERUS ROTUNDUS EXTRACT; DJ 1 PROTEIN; GREEN TEA EXTRACT; HERBACEOUS AGENT; LEUCINE RICH REPEAT KINASE 2; MITOCHONDRIAL DNA; NEUROPROTECTIVE AGENT; OXIDOPAMINE; PARKIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; POLYPHENOL DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROFECOXIB; ROTENONE; SYNTHETIC PEPTIDE; UBIDECARENONE; URIC ACID;

CELL DEATH; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXPERIMENTAL MODEL; GENE IDENTIFICATION; GENE MUTATION; HERBAL MEDICINE; HUMAN; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; UNCARIA;

EID: 79952164540     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.4061/2011/617472     Document Type: Review

References (219)

1. Dauer W., Przedborski S., Parkinson's disease: mechanis (Pubitemid 37130207)
2. Fahn S., The spectrum of levodopa-induced dyskinesias Annals of Neurology 2000 47 4, supplement 1 S2 S11
3. de Lau L. M., Breteler M. M., Epidemiology of Parkinson's disease Lancet Neurology 2006 5 6 525 535 (Pubitemid 44262284)
4. Schuler F., Casida J. E., Functional coupling of PSST and ND1 subunits in NADH:ubiquinone oxidoreductase established by photoaffinity labeling Biochimica et Biophysica ActaBioenergetics 2001 1506 1 79 87 (Pubitemid 32545423)
5. Skehel J. M., Fearnley I. M., Walker J. E., NADH:Ubiquinone oxidoreductase from bovine heart mitochondria: sequence of a novel 17.2-kDa subunit FEBS Letters 1998 438 3 301 305 (Pubitemid 28529294)
6. Blum D., Torch S., Lambeng N., Nissou M. F., Benabid A. L., Sadoul R., Verna J. M., Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Progress in Neurobiology 2001 65 2 135 172 (Pubitemid 32524182)
7. Perier C., Bov J., Wu D. C., Dehay B., Choi D. K., Jackson-Lewis V., Rathke-Hartlieb S., Bouillet P., Strasser A., Schulz J. B., Przedborski S., Vila M., Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 2007 104 19 8161 8166 (Pubitemid 47185892)
8. Hartmann A., Troadec J. D., Hunot S., Kikly K., Faucheux B. A., Mouatt-Prigent A., Ruberg M., Agid Y., Hirsch E. C., Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis Journal of Neuroscience 2001 21 7 2247 2255 (Pubitemid 32240523)
9. Perier C., Tieu K., Gugan C., Caspersen C., Jackson-Lewis V., Carelli V., Martinuzzi A., Hirano M., Przedborski S., Vila M., Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage Proceedings of the National Academy of Sciences of the United States of America 2005 102 52 19126 19131 (Pubitemid 43049577)
10. Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S., Wang X., Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade Cell 1997 91 4 479 489 (Pubitemid 27508237)
11. Vila M., Jackson-Lewis V., Vukosavic S., Djaldetti R., Liberatore G., Offen D., Korsmeyer S. J., Przedborski S., Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 2001 98 5 2837 2842 (Pubitemid 32209570)
12. Hglinger G. U., Carrard G., Michel P. P., Medja F., Lombs A., Ruberg M., Friguet B., Hirsch E. C., Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease Journal of Neurochemistry 2003 86 5 1297 1307 (Pubitemid 37022204)
13. Williams A., MPTP parkinsonism British Medical Journal 1984 289 6456 1401 1402 (Pubitemid 15210956)
14. Langston J. W., Ballard P., Tetrud J. W., Irwin I., Chronic parkinsonism in humans due to a product of meperidine-analog synthesis Science 1983 219 4587 979 980 (Pubitemid 13189531)
15. Buckman T. D., Chang R., Sutphin M. S., Eiduson S., Interaction of 1-methyl-4-phenylpyridinium ion with human platelets Biochemical and Biophysical Research Communications 1988 151 2 897 904 (Pubitemid 18081846)
16. Bov J., Prou D., Perier C., Przedborski S., Toxin-induced models of Parkinson's disease NeuroRx 2005 2 3 484 494 (Pubitemid 41444882)
17. Schapira A. H. V., Cooper J. M., Dexter D., Jenner P., Clark J. B., Marsden C. D., Mitochondrial complex I deficiency in Parkinson's disease Lancet 1989 1 8649 1269 (Pubitemid 19140359)
18. Keeney P. M., Xie J., Capaldi R. A., Bennett J. P., Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled Journal of Neuroscience 2006 26 19 5256 5264 (Pubitemid 44315308)
19. Parker W. D. Jr., Boyson S. J., Parks J. K., Abnormalities of the electron transport chain in idiopathic Parkinson's disease Annals of Neurology 1989 26 6 719 723 (Pubitemid 20011004)
20. Bindoff L. A., Birch-Machin M. A., Cartlidge N. E. F., Parker W. D. Jr., Turnbull D. M., Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease Journal of the Neurological Sciences 1991 104 2 203 208
21. Dexter D. T., Carter C. J., Wells F. R., Javoy-Agid F., Agid Y., Lees A., Jenner P., Marsden C. D., Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease Journal of Neurochemistry 1989 52 2 381 389 (Pubitemid 19037600)
22. Alam Z. I., Daniel S. E., Lees A. J., Marsden D. C., Jenner P., Halliwell B., A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease Journal of Neurochemistry 1997 69 3 1326 1329 (Pubitemid 27364859)
23. Floor E., Wetzel M. G., Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay Journal of Neurochemistry 1998 70 1 268 275 (Pubitemid 28020852)
24. Poirier J., Dea D., Baccichet A., Thiffault C., Superoxide dismutase expression in Parkinson's disease Annals of the New York Academy of Sciences 1994 738 116 120
25. Przedborski S., Jackson-Lewis V., Mechanisms of MPTP toxicity Movement Disorders 1998 13 1 35 38
26. Kitahama K., Denney R. M., Maeda T., Jouvet M., Distribution of type B monoamine oxidase immunoreactivity in the cat brain with reference to enzyme histochemistry Neuroscience 1991 44 1 185 204
27. Przedborski S., Vila M., MPTP: a review of its mechanisms of neurotoxicity Clinical Neuroscience Research 2001 1 6 407 418 (Pubitemid 33665559)
28. Javitch J. A., D'Amato R. J., Strittmatter S. M., Snyder S. H., Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity Proceedings of the National Academy of Sciences of the United States of America 1985 82 7 2173 2177 (Pubitemid 15056491)
29. Mayer R. A., Kindt M. V., Heikkila R. E., Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport Journal of Neurochemistry 1986 47 4 1073 1079 (Pubitemid 16032464)
30. Bezard E., Gross C. E., Fournier M. C., Dovero S., Bloch B., Jaber M., Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter Experimental Neurology 1999 155 2 268 273 (Pubitemid 29124720)
31. Przedborski S., Vila M., The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease Annals of the New York Academy of Sciences 2003 991 189 198 (Pubitemid 36793814)
32. Liu Y., Roghani A., Edwards R. H., Gene transfer of a reserpine-sensitive mechanism of resistance to N- methyl-4-phenylpyridinium Proceedings of the National Academy of Sciences of the United States of America 1992 89 19 9074 9078
33. Klaidman L. K., Adams J. D. Jr., Leung A. C., Kim S. S., Cadenas E., Redox cycling of MPP +: evidence for a new mechanism involving hydride transfer with xanthine oxidase, aldehyde dehydrogenase, and lipoamide dehydrogenase Free Radical Biology and Medicine 1993 15 2 169 179 (Pubitemid 23218819)
34. Ramsay R. R., Singer T. P., Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine, by mitochondria Journal of Biological Chemistry 1986 261 17 7585 7587 (Pubitemid 17208669)
35. Mizuno Y., Saitoh T., Sone N., Inhibition of mitochondrial alpha-ketoglutarate dehydrogenase by 1-methyl-4-phenylpyridinium ion Biochemical and Biophysical Research Communications 1987 143 3 971 976 (Pubitemid 17048365)
36. Ramsay R. R., Krueger M. J., Youngster S. K., Gluck M. R., Casida J. E., Singer T. P., Interaction of 1-methyl-4-phenylpyridinium ion (MPP) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase Journal of Neurochemistry 1991 56 4 1184 1190 (Pubitemid 21902034)
37. Przedborski S., Tieu K., Perier C., Vila M., MPTP as a mitochondrial neurotoxic model of Parkinson's disease Journal of Bioenergetics and Biomembranes 2004 36 4 375 379 (Pubitemid 39619844)
38. Chan P., DeLanney L. E., Irwin I., Langston J. W., Di Monte D., Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain Journal of Neurochemistry 1991 57 1 348 351
39. Fahre E., Monserrat J., Herrero A., Barja G., Leret M. L., Effect of MPTP on brain mitochondrial H 2 O 2 and ATP production and on dopamine and DOPAC in the striatum Journal of Physiology and Biochemistry 1999 55 4 325 332
40. Davey G. P., Clark J. B., Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria Journal of Neurochemistry 1996 66 4 1617 1624 (Pubitemid 26090563)
41. Choi W. S., Kruse S. E., Palmiter R. D., Xia Z., Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP +, or paraquat Proceedings of the National Academy of Sciences of the United States of America 2008 105 39 15136 15141
42. Tieu K., Perier C., Caspersen C., Teismann P., Wu DU. C., Yan S. D., Naini A., Vila M., Jackson-Lewis V., Ramasamy R., Przedborski S., D- -Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease Journal of Clinical Investigation 2003 112 6 892 901 (Pubitemid 38063747)
43. Beal M. F., Rascol, Marek, Olanow, Kordower, Isacson, Stocchi, Schapira, Tatton, Bioenergetic approaches for neuroprotection in Parkinson's disease Annals of Neurology 2003 53 3 S39 S48
44. Liberatore G. T., Jackson-Lewis V., Vukosavic S., Mandir A. S., Vila M., Mcauliffe W. G., Dawson V. L., Dawson T. M., Przedborski S., Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease Nature Medicine 1999 5 12 1403 1409
45. Przedborski S., Kostic V., Jackson-Lewis V., Naini A. B., Simonetti S., Fahn S., Carlson E., Epstein C. J., Cadet J. L., Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity Journal of Neuroscience 1992 12 5 1658 1667
46. Sturtz L. A., Diekert K., Jensen L. T., Lill R., Culotta V. C., A fraction of yeast Cu,Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial oxidative damage Journal of Biological Chemistry 2001 276 41 38084 38089
47. Jenner P., Olanow C. W., Understanding cell death in Parkinson's disease Annals of Neurology 1998 44 3 S72 S84
48. Dehay B., Bov J., Rodrguez-Muela N., Perier C., Recasens A., Boya P., Vila M., Pathogenic lysosomal depletion in Parkinson's disease Journal of Neuroscience 2010 30 37 12535 12544
49. Luzio J. P., Pryor P. R., Bright N. A., Lysosomes: fusion and function Nature Reviews Molecular Cell Biology 2007 8 8 622 632 (Pubitemid 47106614)
50. Malagelada C., Jin Z. H., Jackson-Lewis V., Przedborski S., Greene L. A., Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease Journal of Neuroscience 2010 30 3 1166 1175
51. Elbaz A., Tranchant C., Epidemiologic studies of environmental exposures in Parkinson's disease Journal of the Neurological Sciences 2007 262 1-2 37 44 (Pubitemid 47398893)
52. Gorell J. M., Peterson E. L., Rybicki B. A., Johnson C. C., Multiple risk factors for Parkinson's disease Journal of the Neurological Sciences 2004 217 2 169 174 (Pubitemid 38056551)
53. Sherer T. B., Betarbet R., Testa C. M., Seo B. B., Richardson J. R., Kim J. H., Miller G. W., Yagi T., Matsuno-Yagi A., Greenamyre J. T., Mechanism of toxicity in rotenone models of Parkinson's disease Journal of Neuroscience 2003 23 34 10756 10764 (Pubitemid 37499681)
54. Talpade D. J., Greene J. G., Higgins D. S., Greenamyre J. T., In vivo labeling of mitochondrial complex I (NADH:Ubiquinone oxidoreductase) in rat brain using [ 3 H]dihydrorotenone Journal of Neurochemistry 2000 75 6 2611 2621
55. Sherer T. B., Kim J. H., Betarbet R., Greenamyre J. T., Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and -synuclein aggregation Experimental Neurology 2003 179 1 9 16 (Pubitemid 36062614)
56. Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V., Greenamyre J. T., Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nature Neuroscience 2000 3 12 1301 1306
57. Dawson T. M., Dawson V. L., Molecular pathways of neurodegeneration in Parkinson's disease Science 2003 302 5646 819 822 (Pubitemid 37339614)
58. Pan T., Rawal P., Wu Y., Xie W., Jankovic J., Le W., Rapamycin protects against rotenone-induced apoptosis through autophagy induction Neuroscience 2009 164 2 541 551
59. Senoh S., Creveling C. R., Udenfriend S., Witkop B., Chemical, enzymatic and metabolic studies on the mechanism of oxidation of dopamine Journal of the American Chemical Society 1959 81 23 6236 6240
60. Cohen G., Oxy-radical toxicity in catecholamine neurons NeuroToxicology 1984 5 1 77 82 (Pubitemid 14108953)
61. Kulich S. M., Chu C. T., Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease Journal of Neurochemistry 2001 77 4 1058 1066 (Pubitemid 32467060)
62. Kulich S. M., Horbinski C., Patel M., Chu C. T., 6-Hydroxydopamine induces mitochondrial ERK activation Free Radical Biology and Medicine 2007 43 3 372 383 (Pubitemid 46977632)
63. Margulis L., Symbiosis and evolution Scientific American 1971 225 2 48 57
64. Richter C., Park J. W., Ames B. N., Normal oxidative damage to mitochondrial and nuclear DNA is extensive Proceedings of the National Academy of Sciences of the United States of America 1988 85 17 6465 6467
65. Linnane A. W., Marzuki S., Ozawa T., Tanaka M., Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases Lancet 1989 1 8639 642 645 (Pubitemid 19078788)
66. Michikawa Y., Mazzucchelli F., Bresolin N., Scarlato G., Attardi G., Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication Science 1999 286 5440 774 779
67. Simon D. K., Lin M. T., Zheng L., Liu G. J., Ahn C. H., Kim L. M., Mauck W. M., Twu F., Beal M. F., Johns D. R., Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease Neurobiology of Aging 2004 25 1 71 81 (Pubitemid 37522195)
68. Smigrodzki R., Parks J., Parker W. D., High frequency of mitochondrial complex I mutations in Parkinson's disease and aging Neurobiology of Aging 2004 25 10 1273 1281 (Pubitemid 39299163)
69. Vives-Bauza C., Andreu A. L., Manfredi G., Beal M. F., Janetzky B., Gruenewald T. H., Lin M. T., Sequence analysis of the entire mitochondrial genome in Parkinson's disease Biochemical and Biophysical Research Communications 2002 290 5 1593 1601 (Pubitemid 34687441)
70. Vermulst M., Bielas J. H., Kujoth G. C., Ladiges W. C., Rabinovitch P. S., Prolla T. A., Loeb L. A., Mitochondrial point mutations do not limit the natural lifespan of mice Nature Genetics 2007 39 4 540 543 (Pubitemid 46514771)
71. Kraytsberg Y., Kudryavtseva E., McKee A. C., Geula C., Kowall N. W., Khrapko K., Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons Nature Genetics 2006 38 5 518 520
72. Banerjee R., Starkov A. A., Beal M. F., Thomas B., Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis Biochimica et Biophysica ActaMolecular Basis of Disease 2009 1792 7 651 663
73. Wang Y., Michikawa Y., Mallidis C., Bai Y., Woodhouse L., Yarasheski K. E., Miller C. A., Askanas V., Engel W. K., Bhasin S., Attardi G., Muscle-specific mutations accumulate with aging in critical human mtDNA control sites for replication Proceedings of the National Academy of Sciences of the United States of America 2001 98 7 4022 4027 (Pubitemid 32249891)
74. Aur K., Fayet G., Leroy J. P., Lacne E., Romero N. B., Lombs A., Apoptosis in mitochondrial myopathies is linked to mitochondrial proliferation Brain 2006 129 5 1249 1259
75. Gu M., Cooper J. M., Taanman J. W., Schapira A. H. V., Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease Annals of Neurology 1998 44 2 177 186 (Pubitemid 28374105)
76. Sheehan J. P., Swerdlow R. H., Parker W. D., Miller S. W., Davis R. E., Tuttle J. B., Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease Journal of Neurochemistry 1997 68 3 1221 1233 (Pubitemid 27086228)
77. Bender A., Krishnan K. J., Morris C. M., Taylor G. A., Reeve A. K., Perry R. H., Jaros E., Hersheson J. S., Betts J., Klopstock T., Taylor R. W., Turnbull D. M., High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease Nature Genetics 2006 38 5 515 517
78. Reeve A. K., Krishnan K. J., Turnbull D., Mitochondrial DNA mutations in disease, aging, and neurodegeneration Annals of the New York Academy of Sciences 2008 1147 21 29
79. Ruiz-Pesini E., Mishmar D., Brandon M., Procaccio V., Wallace D. C., Effects of purifying and adaptive selection on regional variation in human mtDNA Science 2004 303 5655 223 226 (Pubitemid 38057570)
80. van der Walt J. M., Nicodemus K. K., Martin E. R., Scott W. K., Nance M. A., Watts R. L., Hubble J. P., Haines J. L., Koller W. C., Lyons K., Pahwa R., Stern M. B., Colcher A., Hiner B. C., Jankovic J., Ondo W. G., Allen F. H., Goetz C. G., Small G. W., Mastaglia F., Stajich J. M., McLaurin A. C., Middleton L. T., Scott B. L., Schmechel D. E., Pericak-Vance M. A., Vance J. M., Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease American Journal of Human Genetics 2003 72 4 804 811 (Pubitemid 36403301)
81. Pyle A., Foltynie T., Tiangyou W., Lambert C., Keers S. M., Allcock L. M., Davison J., Lewis S. J., Perry R. H., Barker R., Burn D. J., Chinnery P. F., Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD Annals of Neurology 2005 57 4 564 567 (Pubitemid 40471169)
82. Autere J., Moilanen J. S., Finnil S., Soininen H., Mannermaa A., Hartikainen P., Hallikainen M., Majamaa K., Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia Human Genetics 2004 115 1 29 35 (Pubitemid 38787215)
83. Lazzarini A. M., Myers R. H., Zimmerman T. R. Jr., Mark M. H., Golbe L. I., Sage J. I., Johnson W. G., Duvoisin R. C., A clinical genetic study of Parkinson's disease: evidence for dominant transmission Neurology 1994 44 3 499 506 (Pubitemid 24098151)
84. Lcking C. B., Drr A., Bonifati V., Vaughan J., De Michele G., Gasser T., Harhangi B. S., Meco G., Denfle P., Wood N. W., Agid Y., Brice A., Nicholl D., Breteler M. M. B., Oostra B. A., De Mari M., Marconi R., Filla A., Bonnet A. M., Broussolle E., Pollak P., Rascol O., Rosier M., Arnould I., Association between early-onset Parkinson's disease and mutations in the parkin gene New England Journal of Medicine 2000 342 21 1560 1567 (Pubitemid 30340501)
85. Bonifati V., Rizzu P., van Baren M. J., Schaap O., Breedveld G. J., Krieger E., Dekker M. C. J., Squitieri F., Ibanez P., Joosse M., Van Dongen J. W., Vanacore N., Van Swieten J. C., Brice A., Meco G., Van Duijn C. M., Oostra B. A., Heutink P., Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism Science 2003 299 5604 256 259 (Pubitemid 36131051)
86. Valente E. M., Abou-Sleiman P. M., Caputo V., Muqit M. M. K., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A. R., Healy D. G., Albanese A., Nussbaum R., Gonzlez-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W. P., Latchman D. S., Harvey R. J., Dallapiccola B., Auburger G., Wood N. W., Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 2004 304 5674 1158 1160 (Pubitemid 38661852)
87. Ueda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., Otero D. A. C., Kondo J., Ihara Y., Saitoh T., Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 1993 90 23 11282 11286 (Pubitemid 23354413)
88. Abeliovich A., Schmitz Y., Farias I., Choi-Lundberg D., Ho W. H., Castillo P. E., Shinsky N., Garcia Verdugo J. M., Armanini M., Ryan A., Hynes M., Phillips H., Sulzer D., Rosenthal A., Mice lacking -synuclein display functional deficits in the nigrostriatal dopamine system Neuron 2000 25 1 239 252 (Pubitemid 30316525)
89. Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Di Iorio G., Golbe L. I., Nussbaum R. L., Mutation in the -synuclein gene identified in families with Parkinson's disease Science 1997 276 5321 2045 2047 (Pubitemid 27443610)
90. Krger R., Kuhn W., Mller T., Woitalla D., Graeber M., Ksel S., Przuntek H., Epplen J. T., Schls L., Riess O., Ala30Pro mutation in the gene encoding -synuclein in Parkinson's disease Nature Genetics 1998 18 2 106 108
91. Zarranz J. J., Alegre J., Gmez-Esteban J. C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atars B., Llorens V., Gomez Tortosa E., Del Ser T., Muoz D. G., De Yebenes J. G., The new mutation, E46K, of -synuclein causes Parkinson and lewy body dementia Annals of Neurology 2004 55 2 164 173 (Pubitemid 38166992)
92. Singleton A. B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M. R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., Gwinn-Hardy K., -synuclein locus triplication causes Parkinson's disease Science 2003 302 5646 841 (Pubitemid 37339619)
93. Bttner S., Bitto A., Ring J., Augsten M., Zabrocki P., Eisenberg T., Jungwirth H., Hutter S., Carmona-Gutierrez D., Kroemer G., Winderickx J., Madeo F., Functional mitochondria are required for -synuclein toxicity in aging yeast Journal of Biological Chemistry 2008 283 12 7554 7560
94. Martin L. J., Pan Y., Price A. C., Sterling W., Copeland N. G., Jenkins N. A., Price D. L., Lee M. K., Parkinson's disease -synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death Journal of Neuroscience 2006 26 1 41 50 (Pubitemid 43089519)
95. Hsu L. J., Sagara Y., Arroyo A., Rockenstein E., Sisk A., Mallory M., Wong J., Takenouchi T., Hashimoto M., Masliah E., -synuclein promotes mitochondrial deficit and oxidative stress American Journal of Pathology 2000 157 2 401 410 (Pubitemid 30627559)
96. Hashimoto M., Takeda A., Hsu L. J., Takenouchi T., Masliah E., Role of cytochrome c as a stimulator of -synuclein aggregation in Lewy body disease Journal of Biological Chemistry 1999 274 41 28849 28852
97. Da Costa C. A., Ancolio K., Checler F., Wild-type but not Parkinson's disease-related Ala-53 → Thr mutant -Synuclein protects neuronal cells from apoptotic stimuli Journal of Biological Chemistry 2000 275 31 24065 24069 (Pubitemid 30624697)
98. Alves Da Costa C., Paitel E., Vincent B., Checler F., -synuclein lowers p53-dependent apoptotic response of neuronal cells: abolishment by 6-hydroxydopamine and implication for Parkinson's disease Journal of Biological Chemistry 2002 277 52 50980 50984 (Pubitemid 36042267)
99. Tanaka Y., Engelender S., Igarashi S., Rao R. K., Wanner T., Tanzi R. E., Sawa A., Dawson V. L., Dawson T. M., Ross C. A., Inducible expression of mutant -synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis Human Molecular Genetics 2001 10 9 919 926 (Pubitemid 32401408)
100. Devi L., Raghavendran V., Prabhu B. M., Avadhani N. G., Anandatheerthavarada H. K., Mitochondrial import and accumulation of -synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain Journal of Biological Chemistry 2008 283 14 9089 9100
101. Parihar M. S., Parihar A., Fujita M., Hashimoto M., Ghafourifar P., Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells International Journal of Biochemistry and Cell Biology 2009 41 10 2015 2024
102. Parihar M. S., Parihar A., Fujita M., Hashimoto M., Ghafourifar P., Mitochondrial association of alpha-synuclein causes oxidative stress Cellular and Molecular Life Sciences 2008 65 7-8 1272 1284
103. Lee HE. J., Shin S. Y., Choi C., Lee Y. H., Lee S. J., Formation and removal of -synuclein aggregates in cells exposed to mitochondrial inhibitors Journal of Biological Chemistry 2002 277 7 5411 5417 (Pubitemid 34968588)
104. Dauer W., Kholodilov N., Vila M., Trillat A. C., Goodchild R., Larsen K. E., Staal R., Tieu K., Schmitz Y., Yuan C. A., Rocha M., Jackson-Lewis V., Hersch S., Sulzer D., Przedborski S., Burke R., Hen R., Resistance of -synuclein null mice to the parkinsonian neurotoxin MPTP Proceedings of the National Academy of Sciences of the United States of America 2002 99 22 14524 14529 (Pubitemid 35257704)
105. Klivenyi P., Siwek D., Gardian G., Yang L., Starkov A., Cleren C., Ferrante R. J., Kowall N. W., Abeliovich A., Beal M. F., Mice lacking alpha-synuclein are resistant to mitochondrial toxins Neurobiology of Disease 2006 21 3 541 548 (Pubitemid 43277537)
106. Cole N. B., DiEuliis D., Leo P., Mitchell D. C., Nussbaum R. L., Mitochondrial translocation of -synuclein is promoted by intracellular acidification Experimental Cell Research 2008 314 10 2076 2089
107. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N., Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 1998 392 6676 605 608 (Pubitemid 28207717)
108. West A. B., Maidment N. T., Genetics of parkin-linked disease Human Genetics 2004 114 4 327 336 (Pubitemid 38324945)
109. Moore D. J., Parkin: a multifaceted ubiquitin ligase Biochemical Society Transactions 2006 34 5 749 753 (Pubitemid 44796412)
110. Shimura H., Hattori N., Kubo S. I., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K., Suzuki T., Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase Nature Genetics 2000 25 3 302 305 (Pubitemid 30437317)
111. Pickart C. M., Fushman D., Polyubiquitin chains: polymeric protein signals Current Opinion in Chemical Biology 2004 8 6 610 616 (Pubitemid 39535722)
112. Darios F., Corti O., Lcking C. B., Hampe C., Muriel M. P., Abbas N., Gu W. J., Hirsch E. C., Rooney T., Ruberg M., Brice A., Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death Human Molecular Genetics 2003 12 5 517 526 (Pubitemid 36305590)
113. Berger A. K., Cortese G. P., Amodeo K. D., Weihofen A., Letai A., LaVoie M. J., Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release Human Molecular Genetics 2009 18 22 4317 4328
114. Kuroda Y., Mitsui T., Kunishige M., Shono M., Akaike M., Azuma H., Matsumoto T., Parkin enhances mitochondrial biogenesis in proliferating cells Human Molecular Genetics 2006 15 6 883 895 (Pubitemid 43338230)
115. Palacino J. J., Sagi D., Goldberg M. S., Krauss S., Motz C., Wacker M., Klose J., Shen J., Mitochondrial dysfunction and oxidative damage in parkin-deficient mice Journal of Biological Chemistry 2004 279 18 18614 18622 (Pubitemid 38623283)
116. Goldberg M. S., Fleming S. M., Palacino J. J., Cepeda C., Lam H. A., Bhatnagar A., Meloni E. G., Wu N., Ackerson L. C., Klapstein G. J., Gajendiran M., Roth B. L., Chesselet M. F., Maidment N. T., Levine M. S., Shen J., Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons Journal of Biological Chemistry 2003 278 44 43628 43635 (Pubitemid 37345989)
117. Stichel C. C., Zhu X. R., Bader V., Linnartz B., Schmidt S., Lbbert H., Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage Human Molecular Genetics 2007 16 20 2377 2393 (Pubitemid 47514484)
118. Mortiboys H., Thomas K. J., Koopman W. J. H., Klaffke S., Abou-Sleiman P., Olpin S., Wood N. W., Willems P. H. G. M., Smeitink J. A. M., Cookson M. R., Bandmann O., Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts Annals of Neurology 2008 64 5 555 565
119. Pesah Y., Pham T., Burgess H., Middlebrooks B., Verstreken P., Zhou YI., Harding M., Bellen H., Mardon G., Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress Development 2004 131 9 2183 2194 (Pubitemid 38702049)
120. Rothfuss O., Fischer H., Hasegawa T., Maisel M., Leitner P., Miesel F., Sharma M., Bornemann A., Berg D., Gasser T., Patenge N., Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair Human Molecular Genetics 2009 18 20 3832 3850
121. Deng H., Jankovic J., Guo Y., Xie W., Le W., Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y Biochemical and Biophysical Research Communications 2005 337 4 1133 1138 (Pubitemid 41505244)
122. Petit A., Kawarai T., Paitel E., Sanjo N., Maj M., Scheid M., Chen F., Gu Y., Hasegawa H., Salehi-Rad S., Wang L., Rogaeva E., Fraser P., Robinson B., George -. P. ST., Tandon A., Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations Journal of Biological Chemistry 2005 280 40 34025 34032 (Pubitemid 41443124)
123. Haque M. E., Thomas K. J., D'Souza C., Callaghan S., Kitada T., Slack R. S., Fraser P., Cookson M. R., Tandon A., Park D. S., Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP Proceedings of the National Academy of Sciences of the United States of America 2008 105 5 1716 1721 (Pubitemid 351346580)
124. Gandhi S., Muqit M. M. K., Stanyer L., Healy D. G., Abou-Sleiman P. M., Hargreaves I., Heales S., Ganguly M., Parsons L., Lees A. J., Latchman D. S., Holton J. L., Wood N. W., Revesz T., PINK1 protein in normal human brain and Parkinson's disease Brain 2006 129 7 1720 1731 (Pubitemid 43999406)
125. Zhou C., Huang Y., Shao Y., May J., Prou D., Perier C., Dauer W., Schon E. A., Przedborski S., The kinase domain of mitochondrial PINK1 faces the cytoplasm Proceedings of the National Academy of Sciences of the United States of America 2008 105 33 12022 12027
126. Clark I. E., Dodson M. W., Jiang C., Cao J. H., Huh J. R., Seol J. H., Yoo S. J., Hay B. A., Guo M., Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin Nature 2006 441 7097 1162 1166 (Pubitemid 43990738)
127. Park J., Lee S. B., Lee S., Kim Y., Song S., Kim S., Bae E., Kim J., Shong M., Kim J. M., Chung J., Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin Nature 2006 441 7097 1157 1161 (Pubitemid 43990737)
128. Yang Y., Gehrke S., Imai Y., Huang Z., Ouyang Y., Wang JI. W., Yang L., Beal M. F., Vogel H., Lu B., Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin Proceedings of the National Academy of Sciences of the United States of America 2006 103 28 10793 10798 (Pubitemid 44078055)
129. Exner N., Treske B., Paquet D., Holmstrm K., Schiesling C., Gispert S., Carballo-Carbajal I., Berg D., Hoepken H. H., Gasser T., Krger R., Winklhofer K. F., Vogel F., Reichert A. S., Auburger G., Kahle P. J., Schmid B., Haass C., Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin Journal of Neuroscience 2007 27 45 12413 12418 (Pubitemid 350085485)
130. Goldman Scott S. J., Taylor R., Zhang Y., Jin S., Autophagy and the degradation of mitochondria Mitochondrion 2010 10 4 309 315
131. Kim I., Rodriguez-Enriquez S., Lemasters J. J., Selective degradation of mitochondria by mitophagy Archives of Biochemistry and Biophysics 2007 462 2 245 253 (Pubitemid 46876640)
132. Chinta S. J., Mallajosyula J. K., Rane A., Andersen J. K., Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo Neuroscience Letters 2010 486 3 235 239
133. Chu Y., Dodiya H., Aebischer P., Olanow C. W., Kordower J. H., Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions Neurobiology of Disease 2009 35 3 385 398
134. Cullen V., Lindfors M., Ng J., Paetau A., Swinton E., Kolodziej P., Boston H., Saftig P., Woulfe J., Feany M. B., Myllykangas L., Schlossmacher M. G., Tyynel J., Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo Molecular Brain 2009 2 1, article 5
135. Narendra D., Tanaka A., Suen D. F., Youle R. J., Parkin is recruited selectively to impaired mitochondria and promotes their autophagy Journal of Cell Biology 2008 183 5 795 803
136. Narendra D. P., Jin S. M., Tanaka A., Suen D. F., Gautier C. A., Shen J., Cookson M. R., Youle R. J., PINK1 is selectively stabilized on impaired mitochondria to activate Parkin PLoS Biology 2010 8 1
137. Matsuda N., Sato S., Shiba K., Okatsu K., Saisho K., Gautier C. A., Sou YU. S., Saiki S., Kawajiri S., Sato F., Kimura M., Komatsu M., Hattori N., Tanaka K., PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy Journal of Cell Biology 2010 189 2 211 221
138. Ruan Q., Harrington A. J., Caldwell K. A., Caldwell G. A., Standaert D. G., VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease Neurobiology of Disease 2010 37 2 330 338
139. Vives-Bauza C., Zhou C., Huang Y., Cui M., De Vries R. L. A., Kim J., May J., Tocilescu M. A., Liu W., Ko H. S., Magran J., Moore D. J., Dawson V. L., Grailhe R., Dawson T. M., Li C., Tieu K., Przedborski S., PINK1-dependent recruitment of Parkin to mitochondria in mitophagy Proceedings of the National Academy of Sciences of the United States of America 2010 107 1 378 383
140. Dagda R. K., Cherra S. J. III, Kulich S. M., Tandon A., Park D., Chu C. T., Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission Journal of Biological Chemistry 2009 284 20 13843 13855
141. Deng H., Dodson M. W., Huang H., Guo M., The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila Proceedings of the National Academy of Sciences of the United States of America 2008 105 38 14503 14508
142. Poole A. C., Thomas R. E., Andrews L. A., McBride H. M., Whitworth A. J., Pallanck L. J., The PINK1/Parkin pathway regulates mitochondrial morphology Proceedings of the National Academy of Sciences of the United States of America 2008 105 5 1638 1643 (Pubitemid 351346567)
143. Park J., Lee G., Chung J., The PINK1-Parkin pathway is involved in the regulation of mitochondrial remodeling process Biochemical and Biophysical Research Communications 2009 378 3 518 523
144. Gautier C. A., Kitada T., Shen J., Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress Proceedings of the National Academy of Sciences of the United States of America 2008 105 32 11364 11369
145. Piccoli C., Sardanelli A., Scrima R., Ripoli M., Quarato G., D'Aprile A., Bellomo F., Scacco S., De Michele G., Filla A., Iuso A., Boffoli D., Capitanio N., Papa S., Mitochondrial respiratory dysfunction in familiar Parkinsonism associated with PINK1 mutation Neurochemical Research 2008 33 12 2565 2574
146. Taira T., Saito Y., Niki T., Iguchi-Ariga S. M. M., Takahashi K., Ariga H., DJ-1 has a role in antioxidative stress to prevent cell death EMBO Reports 2004 5 2 213 218 (Pubitemid 38401204)
147. Lev N., Ickowicz D., Melamed E., Offen D., Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection NeuroToxicology 2008 29 3 397 405
148. Meulener M., Whitworth A. J., Armstrong-Gold C. E., Rizzu P., Heutink P., Wes P. D., Pallanck L. J., Bonini N. M., Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease Current Biology 2005 15 17 1572 1577 (Pubitemid 41219597)
149. Meulener M. C., Xu K., Thompson L., Ischiropoulos H., Bonini N. M., Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging Proceedings of the National Academy of Sciences of the United States of America 2006 103 33 12517 12522 (Pubitemid 44267290)
150. Kim R. H., Smith P. D., Aleyasin H., Hayley S., Mount M. P., Pownall S., Wakeham A., You-Ten A. J., Kalia S. K., Horne P., Westaway D., Lozano A. M., Anisman H., Park D. S., Mak T. W., Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyrindine (MPTP) and oxidative stress Proceedings of the National Academy of Sciences of the United States of America 2005 102 14 5215 5220
151. Martinat C., Shendelman S., Jonason A., Leete T., Beal M. F., Yang L., Floss T., Abeliovich A., Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary Parkinsonism PLoS Biology 2004 2 11
152. Shendelman S., Jonason A., Martinat C., Leete T., Abeliovich A., DJ-1 is a redox-dependent molecular chaperone that inhibits -synuclein aggregate formation PLoS Biology 2004 2 11, article e362
153. Yang W., Chen L., Ding Y., Zhuang X., Kang U. J., Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice Human Molecular Genetics 2007 16 23 2900 2910 (Pubitemid 350048387)
154. Im J. Y., Lee K. W., Junn E., Mouradian M. M., DJ-1 protects against oxidative damage by regulating the thioredoxin/ASK1 complex Neuroscience Research 2010 67 3 203 208
155. Hayashi T., Ishimori C., Takahashi-Niki K., Taira T., Kim Y. C., Maita H., Maita C., Ariga H., Iguchi-Ariga S. M. M., DJ-1 binds to mitochondrial complex I and maintains its activity Biochemical and Biophysical Research Communications 2009 390 3 667 672
156. Andres-Mateos E., Perier C., Zhang L., Blanchard-Fillion B., Greco T. M., Thomas B., Han S. K., Sasaki M., Ischiropoulos H., Przedborski S., Dawson T. M., Dawson V. L., DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase Proceedings of the National Academy of Sciences of the United States of America 2007 104 37 14807 14812 (Pubitemid 350003224)
157. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R. J., Calne D. B., Stoessl A. J., Pfeiffer R. F., Patenge N., Carbajal I. C., Vieregge P., Asmus F., Mller-Myhsok B., Dickson D. W., Meitinger T., Strom T. M., Wszolek Z. K., Gasser T., Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 2004 44 4 601 607 (Pubitemid 39531225)
158. Bosgraaf L., van Haastert P. J. M., Roc, a Ras/GTPase domain in complex proteins Biochimica et Biophysica ActaMolecular Cell Research 2003 1643 13 5 10 (Pubitemid 37494887)
159. West A. B., Moore D. J., Biskup S., Bugayenko A., Smith W. W., Ross C. A., Dawson V. L., Dawson T. M., Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity Proceedings of the National Academy of Sciences of the United States of America 2005 102 46 16842 16847 (Pubitemid 41688864)
160. Gloeckner C. J., Kinkl N., Schumacher A., Braun R. J., O'Neill E., Meitinger T., Kolch W., Prokisch H., Ueffing M., The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity Human Molecular Genetics 2006 15 2 223 232 (Pubitemid 43125977)
161. Andres-Mateos E., Mejias R., Sasaki M., Li X., Lin B. M., Biskup S., Zhang LI., Banerjee R., Thomas B., Yang L., Liu G., Beal M. F., Huso D. L., Dawson T. M., Dawson V. L., Unexpected lack of hypersensitivity in LRRK2 knock-out mice to MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) Journal of Neuroscience 2009 29 50 15846 15850
162. West A. B., Moore D. J., Choi C., Andrabi S. A., Li X., Dikeman D., Biskup S., Zhang Z., Lim K. L., Dawson V. L., Dawson T. M., Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity Human Molecular Genetics 2007 16 2 223 232 (Pubitemid 46179004)
163. Lin X., Parisiadou L., Gu X. L., Wang L., Shim H., Sun L., Xie C., Long C. X., Yang W. J., Ding J., Chen Z. Z., Gallant P. E., Tao-Cheng J. H., Rudow G., Troncoso J. C., Liu Z., Li Z., Cai H., Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease- related mutant -synuclein Neuron 2009 64 6 807 827
164. Carballo-Carbajal I., Weber-Endress S., Rovelli G., Chan D., Wolozin B., Klein C. L., Patenge N., Gasser T., Kahle P. J., Leucine-rich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathway Cellular Signalling 2010 22 5 821 827
165. Tong Y., Yamaguchi H., Giaime E., Boyle S., Kopan R., Kelleher R. J., Shen J., Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of -synuclein, and apoptotic cell death in aged mice Proceedings of the National Academy of Sciences of the United States of America 2010 107 21 9879 9884
166. Heo H. Y., Park J. M., Kim C. H., Han B. S., Kim K. S., Seol W., LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity Experimental Cell Research 2010 316 4 649 656
167. Naderi J., Somayajulu-Nitu M., Mukerji A., Sharda P., Sikorska M., Borowy-Borowski H., Antonsson B., Pandey S., Water-soluble formulation of Coenzyme Q 10 inhibits Bax-induced destabilization of mitochondria in mammalian cells Apoptosis 2006 11 8 1359 1369 (Pubitemid 44035947)
168. Papucci L., Schiavone N., Witort E., Donnini M., Lapucci A., Tempestini A., Formigli L., Zecchi-Orlandini S., Orlandini G., Carella G., Brancato R., Capaccioli S., Coenzyme Q 10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property Journal of Biological Chemistry 2003 278 30 28220 28228 (Pubitemid 36900022)
169. Littarru G. P., Tiano L., Bioenergetic and antioxidant properties of coenzyme Q: recent developments Molecular Biotechnology 2007 37 1 31 37 (Pubitemid 350135901)
170. Shults C. W., Haas R. H., Passov D., Beal M. F., Coenzyme Q 10 levels correlate with the activities of complexes I and II/III in mitochondria from Parkinsonian and nonparkinsonian subjects Annals of Neurology 1997 42 2 261 264 (Pubitemid 27340475)
171. Reeve A. K., Krishnan K. J., Turnbull D., Mitochondrial DNA mutations in disease, aging, and neurodegeneration Annals of the New York Academy of Sciences 2008 1147 21 29
172. McCarthy S., Somayajulu M., Sikorska M., Borowy-Borowski H., Pandey S., Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q Toxicology and Applied Pharmacology 2004 201 1 21 31 (Pubitemid 39446323)
173. Moon Y., Lee K. H., Park J. H., Geum D., Kim K., Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q Journal of Neurochemistry 2005 93 5 1199 1208 (Pubitemid 40776574)
174. Beal M. F., Matthews R. T., Tieleman A., Shults C. W., Coenzyme Q 10 attenuates the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice Brain Research 1998 783 1 109 114 (Pubitemid 28131427)
175. Matthews R. T., Yang L., Browne S., Baik M., Beal M. F., Coenzyme Q 10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects Proceedings of the National Academy of Sciences of the United States of America 1998 95 15 8892 8897
176. Shults C. W., Oakes D., Kieburtz K., Flint Beal M., Haas R., Plumb S., Juncos J. L., Nutt J., Shoulson I., Carter J., Kompoliti K., Perlmutter J. S., Reich S., Stern M., Watts R. L., Kurlan R., Molho E., Harrison M., Lew M., Effects of coenzyme Q 10 in early Parkinson disease: evidence of slowing of the functional decline Archives of Neurology 2002 59 10 1541 1550
177. Storch A., Jost W. H., Vieregge P., Spiegel J., Greulich W., Durner J., MLler T., Kupsch A., Henningsen H., Oertel W. H., Fuchs G., Kuhn W., Niklowitz P., Koch R., Herting B., Reichmann H., Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q 10 in Parkinson disease Archives of Neurology 2007 64 7 938 944 (Pubitemid 47047992)
178. Beal M. F., Effects of Coenzyme Q10 (CoQ) in Parkinson Disease (QE3). 2010, http://clinicaltrials.gov/ct2/show/NCT00740714?term=QE3+Parkinson27srank=1
179. Klivenyi P., Ferrante R. J., Matthews R. T., Bogdanov M. B., Klein A. M., Andreassen O. A., Mueller G., Wermer M., Kaddurah-Daouk R., Beal M. F., Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis Nature Medicine 1999 5 3 347 350 (Pubitemid 29124375)
180. Brewer G. J., Wallimann T. W., Protective effect of the energy precursor creatine against toxicity of glutamate and -amyloid in rat hippocampal neurons Journal of Neurochemistry 2000 74 5 1968 1978 (Pubitemid 30217652)
181. Ferrante R. J., Andreassen O. A., Jenkins B. G., Dedeoglu A., Kuemmerle S., Kubilus J. K., Kaddurah-Daouk R., Hersch S. M., Beal M. F., Neuroprotective effects of creatine in a transgenic Mouse model of Huntington's disease Journal of Neuroscience 2000 20 12 4389 4397 (Pubitemid 30396603)
182. Andres R. H., Huber A. W., Schlattner U., Prez-Bouza A., Krebs S. H., Seiler R. W., Wallimann T., Widmer H. R., Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue Neuroscience 2005 133 3 701 713 (Pubitemid 40798323)
183. Matthews R. T., Ferrante R. J., Klivenyi P., Yang L., Klein A. M., Mueller G., Kaddurah-Daouk R., Beal M. F., Creatine and cyclocreatine attenuate MPTP neurotoxicity Experimental Neurology 1999 157 1 142 149 (Pubitemid 29226877)
184. Klivenyi P., Gardian G., Calingasan N. Y., Yang L., Beal M. F., Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) mouse model of Parkinson's disease Journal of Molecular Neuroscience 2003 21 3 191 198 (Pubitemid 39117969)
185. Bender A., Beckers J., Schneider I., Hlter S. M., Haack T., Ruthsatz T., Vogt-Weisenhorn D. M., Becker L., Genius J., Rujescu D., Irmler M., Mijalski T., Mader M., Quintanilla-Martinez L., Fuchs H., Gailus-Durner V., de Angelis M. H., Wurst W., Schmidt J., Klopstock T., Creatine improves health and survival of mice Neurobiology of Aging 2008 29 9 1404 1411 (Pubitemid 351970598)
186. Bender A., Koch W., Elstner M., Schombacher Y., Bender J., Moeschl M., Gekeler F., Mller-Myhsok B., Gasser T., Tatsch K., Klopstock T., Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial Neurology 2006 67 7 1262 1264 (Pubitemid 44563840)
187. Couzin J., Clinical research. Testing a novel strategy against Parkinson's disease Science 2007 315 5820 1778
188. Yang L., Calingasan N. Y., Wille E. J., Cormier K., Smith K., Ferrante R. J., Flint Beal M., Combination therapy with Coenzyme Q 10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's Diseases Journal of Neurochemistry 2009 109 5 1427 1439
189. Zhao K., Luo G., Zhao G. M., Schiller P. W., Szeto H. H., Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide Journal of Pharmacology and Experimental Therapeutics 2003 304 1 425 432 (Pubitemid 36008956)
190. Zhao K., Zhao G. M., Wu D., Soong YI., Birk A. V., Schiller P. W., Szeto H. H., Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury Journal of Biological Chemistry 2004 279 33 34682 34690 (Pubitemid 39318098)
191. Szeto H. H., Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury Antioxidants and Redox Signaling 2008 10 3 601 619
192. Szeto H. H., Development of mitochondria-targeted aromatic-cationic peptides for neurodegenerative diseases Annals of the New York Academy of Sciences 2008 1147 112 121
193. Zhao K., Luo G., Giannelli S., Szeto H. H., Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines Biochemical Pharmacology 2005 70 12 1796 1806 (Pubitemid 41612010)
194. Yang L., Zhao K., Calingasan N. Y., Luo G., Szeto H. H., Beal M. F., Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity Antioxidants and Redox Signaling 2009 11 9 2095 2104
195. Nijveldt R. J., van Nood E., van Hoorn D. E. C., Boelens P. G., van Norren K., van Leeuwen P. A. M., Flavonoids: a review of probable mechanisms of action and potential applications American Journal of Clinical Nutrition 2001 74 4 418 425 (Pubitemid 32880250)
196. Guo S., Bezard E., Zhao B., Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway Free Radical Biology and Medicine 2005 39 5 682 695 (Pubitemid 41112109)
197. Levites Y., Weinreb O., Maor G., Youdim M. B. H., Mandel S., Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration Journal of Neurochemistry 2001 78 5 1073 1082 (Pubitemid 32823156)
198. Choi JI. Y., Park C. S., Kim D. J., Cho M. H., Jin B. K., Pie J. E., Chung W. G., Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate NeuroToxicology 2002 23 3 367 374
199. Griffioen G., Duhamel H., van Damme N., Pellens K., Zabrocki P., Pannecouque C., Van Leuven F., Winderickx J., Wera S., A yeast-based model of -synucleinopathy identifies compounds with therapeutic potential Biochimica et Biophysica ActaMolecular Basis of Disease 2006 1762 3 312 318 (Pubitemid 43172846)
200. Chan D. K. Y., Woo J., Ho S. C., Pang C. P., Law L. K., Ng P. W., Hung W. T., Kwok T., Hui E., Orr K., Leung M. F., Kay R., Genetic and environmental risk factors for Parkinson's disease in a Chinese population Journal of Neurology Neurosurgery and Psychiatry 1998 65 5 781 784 (Pubitemid 28486664)
201. Lorenz P., Roychowdhury S., Engelmann M., Wolf G., Horn T. F. W., Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived from microglial cells Nitric OxideBiology and Chemistry 2003 9 2 64 76 (Pubitemid 37386375)
202. Chao J., Yu M. S., Ho Y. S., Wang M., Chang R. C. C., Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity Free Radical Biology and Medicine 2008 45 7 1019 1026
203. Andrabi S. A., Spina M. G., Lorenz P., Ebmeyer U., Wolf G., Horn T. F. W., Oxyresveratrol (trans-2,3′,4,5′-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia Brain Research 2004 1017 1-2 98 107 (Pubitemid 38917149)
204. Ames B. N., Cathcart R., Schwiers E., Hochstein P., Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis Proceedings of the National Academy of Sciences of the United States of America 1981 78 11 6858 6862 (Pubitemid 12216861)
205. Davis J. W., Grandinetti A., Waslien C. I., Ross G. W., White L. R., Morens D. M., Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease American Journal of Epidemiology 1996 144 5 480 484 (Pubitemid 26296131)
206. Annanmaki T., Muuronen A., Murros K., Low plasma uric acid level in Parkinson's disease Movement Disorders 2007 22 8 1133 1137 (Pubitemid 47067223)
207. Weisskopf M. G., O'Reilly E., Chen H., Schwarzschild M. A., Ascherio A., Plasma urate and risk of Parkinson's disease American Journal of Epidemiology 2007 166 5 561 567 (Pubitemid 47283643)
208. Winquist A., Steenland K., Shankar A., Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community-based survey Movement Disorders 2010 25 7 932 936
209. Anderson R. F., Harris T. A., Dopamine and uric acid act as antioxidants in the repair of DNA radicals: implications in Parkinson's disease Free Radical Research 2003 37 10 1131 1136 (Pubitemid 37265336)
210. Duan W., Ladenheim B., Cutler R. G., Kruman I. I. III, Cadet J. L., Mattson M. P., Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease Journal of Neurochemistry 2002 80 1 101 110 (Pubitemid 34614582)
211. Guerreiro S., Ponceau A., Toulorge D., Martin E., Alvarez-Fischer D., Hirsch E. C., Michel P. P., Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization Journal of Neurochemistry 2009 109 4 1118 1128
212. Yacoubian T. A., Standaert D. G., Targets for neuroprotection in Parkinson's disease Biochimica et Biophysica ActaMolecular Basis of Disease 2009 1792 7 676 687
213. Schwarzschild M. A., Safety of Urate Elevation in Parkinson's Disease (SURE-PD). November 2010, http://clinicaltrials.gov/ct2/show/NCT00833690?term= uric+acidrank=6
214. Lee C. H., Hwang D. S., Kim H. G., Oh H., Park H., Cho J. H., Lee J. M., Jang J. B., Lee K. S., Oh M. S., Protective effect of Cyperi Rhizoma against 6-hydroxydopamine-induced neuronal damage Journal of Medicinal Food 2010 13 3 564 571
215. Lee J., Son D., Lee P., Kim D. K., Shin M. C., Jang MI. H., Kim C. J., Kim Y. S., Kim S. Y., Kim H., Protective effect of methanol extract of Uncaria rhynchophylla against excitotoxicity induced by N-methyl-D-aspartate in rat hippocampus Journal Pharmacological Sciences 2003 92 1 70 73 (Pubitemid 36705669)
216. Ma B., Wu C. F., Yang J. Y., Wang R., Kano Y., Yuan D., Three new alkaloids from the leaves of Uncaria rhynchophylla Helvetica Chimica Acta 2009 92 8 1575 1585
217. Shim J. S., Kim H. G., Ju M. S., Choi J. G., Jeong S. Y., Oh M. S., Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease Journal of Ethnopharmacology 2009 126 2 361 365
218. Koller W., Olanow C. W., Rodnitzky R., Fink J. S., Growdon J. H., Paulson G., Kurlan R., Friedman J. H., Gancher S., Nutt J., Rajput A. H., Bennett J. B., Wooten G. F., LeWitt P., Goetz C., Tanner C., Shannon K., Suchowersky O., Brin M. F., Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease New England Journal of Medicine 1993 328 3 176 183 (Pubitemid 23021504)
219. Snow B. J., Rolfe F. L., Lockhart M. M., Frampton C. M., O'Sullivan J. D., Fung V., Smith R. A. J., Murphy M. P., Taylor K. M., A double-blind, placebo-controlled study to assess the mitochondria- targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease Movement Disorders 2010 25 11 1670 1674